Ontology highlight
ABSTRACT: Objective
To determine whether better medication adherence in multiple sclerosis (MS) might be due to specialised disease-modifying drug (DMD) support programmes by: (1) establishing higher adherence in MS than in other chronic diseases and (2) determining if higher adherence is associated with patient-specific or treatment-specific factors.Design
Retrospective cohort study with data from 1 January 1996 to 31 December 2015.Setting
Population-based health administrative data from three Canadian provinces.Participants
Individual cohorts were created using validated case definitions for MS, epilepsy, Parkinson's disease (PD) and rheumatoid arthritis (RA). Subjects were included if they received ≥1 dispensation for a disease-related drug between 1 January 1997 a
SUBMITTER: Evans C
PROVIDER: S-EPMC7925877 | biostudies-literature | 2021 Feb
REPOSITORIES: biostudies-literature